Average Co-Inventor Count = 11.69
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (18 from 2,405 patents)
2. Msd R&d (china) Co., Ltd. (2 from 10 patents)
3. Merck + Co., Inc. (1 from 4,770 patents)
4. Merck Canada Inc. (1 from 40 patents)
5. Msd R&d Co., Ltd. (0 patent)
19 patents:
1. 12466831 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
2. 12414952 - Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use
3. 12263171 - 7-, 8-, and 10-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
4. 12060357 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
5. 11566057 - Long-acting co-agonists of the glucagon and GLP-1 receptors
6. 11492385 - Long-acting co-agonists of the glucagon and GLP-1 receptors
7. 11339156 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
8. 11312719 - 9-substituted amino triazolo quinazoline derivatives as adenosine receptor antagonists, pharmaceutical compositions and their use
9. 11149036 - 3-(1H-pyrazol-4-yl)pyridine allosteric modulators of the M4 muscarinic acetylcholine receptor
10. 10793615 - Long-acting co-agonists of the glucagon and GLP-1 receptors
11. 10472347 - Aminopyrazine compounds with A2A antagonist properties
12. 10413593 - Co-agonists of the glucagon and GLP-1 receptors
13. 10011615 - Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with A2A anatagonist properties
14. 9745295 - Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
15. 9676780 - [object Object]